Response to: “A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial”

• Annelise Madison,
• Barbara L. Andersen,
• Ali Ajam

Affiliations

Annelise Madison

Institute for Behavioral Medicine Research, The Ohio State University College of Medicine

Barbara L. Andersen

Department of Psychology, The Ohio State University

Ali Ajam

Division of Rheumatology and Immunology, The Ohio State University College of Medicine